Navamedic Q4 and full year 2023: A year marked by new records and transformative growth initiatives

Publisert: 15.02.2024

Navamedic ASA: Invitation to 2023 4th quarter presentation

Publisert: 13.02.2024

Navamedic ASA launches Eroxon®

Publisert: 12.02.2024

Navamedic ASA: Renewed contract signed with Vitaflo International Limited

Publisert: 21.12.2023

Navamedic and Orion Corporation sign non-binding term sheet for Flexilev® in Europe

Publisert: 13.12.2023

Navamedic ASA: Record high quarter with above 50 percent growth

Publisert: 01.11.2023